-
First-in-world BC patient successfully treated for rare immune disease
A new paper published in New England Journal of Medicine details how an 18-year-old patient being treated at BC Children’s Hospital (BCCH) for a rare disease called chronic granulomatous disease (CGD) became the first person ever to receive and be cured by a gene modification treatment known as “Prime Editing.”
-
Improving care for kids with the most common childhood cancers: Q&A with new investigator Dr. Sarah Alexander
February 15 was International Childhood Cancer Day and to mark the occasion we spoke with Dr. Sarah Alexander, a new BCCHR investigator and pediatric oncologist at BC Children’s Hospital who specializes in some of the most common childhood cancers, including non-Hodgkin lymphoma and acute lymphoblastic leukemia (ALL).
-
Collaboration led by BCCHR researchers awarded European funding to improve community-based care in Uganda and Kenya
Dr. Matthew Wiens and colleagues at the Institute for Global Health at BC Children’s & Women’s Hospital, BC Children’s Research Institute, and the University of British Columbia, are the first Canadian Team to lead a Horizon Europe Pillar 2 project. The consortium was recently awarded €5 million under the Global Health EDCTP3 Joint Undertaking for a project that…
